Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Food and Agriculture
by ruth on April 30, 2006

Phospa E is patented vitamin E phosphate, said to protect the antioxidant potential of vitamin E during absorption, transport and storage in the body. It is currently only marketed in the US, Canada and Indonesia by Zila Nutraceuticals, which markets it as Ester-E.
Nestle Nutrition may use Phospha E to develop nutritional products that target the prevention and treatment of metabolic syndrome, a group of risk factors for heart disease, including excessive weight, high blood pressure, high blood sugar and triglyceride concentrations, and other factors contributing to cardiovascular disease.
See Nutraingredients.com for a feature report. Other public details of the agreement may be found here.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/21026
Mr Wong
Vote for Phosphagenics and Nestle Nutrition Enters Research Agreement:
|
Rating: 6.00 out of 1 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







